Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2007 1
2008 2
2009 4
2010 1
2011 2
2013 4
2014 6
2015 6
2016 4
2017 1
2018 3
2019 7
2020 8
2021 5
2022 6
2023 3
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
The cephalic phase of insulin release is modulated by IL-1β.
Wiedemann SJ, Trimigliozzi K, Dror E, Meier DT, Molina-Tijeras JA, Rachid L, Le Foll C, Magnan C, Schulze F, Stawiski M, Häuselmann SP, Méreau H, Böni-Schnetzler M, Donath MY. Wiedemann SJ, et al. Among authors: le foll c. Cell Metab. 2022 Jul 5;34(7):991-1003.e6. doi: 10.1016/j.cmet.2022.06.001. Epub 2022 Jun 23. Cell Metab. 2022. PMID: 35750050 Free article.
Amylin brain circuitry.
Boccia L, Gamakharia S, Coester B, Whiting L, Lutz TA, Le Foll C. Boccia L, et al. Among authors: le foll c. Peptides. 2020 Oct;132:170366. doi: 10.1016/j.peptides.2020.170366. Epub 2020 Jul 4. Peptides. 2020. PMID: 32634450 Free article. Review.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Guigay J, Aupérin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, Geoffrois L, Martin L, Capitain O, Cupissol D, Castanie H, Vansteene D, Schafhausen P, Johnson A, Even C, Sire C, Duplomb S, Evrard C, Delord JP, Laguerre B, Zanetta S, Chevassus-Clément C, Fraslin A, Louat F, Sinigaglia L, Keilholz U, Bourhis J, Mesia R; GORTEC; AIO; TTCC, and UniCancer Head and Neck groups. Guigay J, et al. Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5. Lancet Oncol. 2021. PMID: 33684370 Clinical Trial.
Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing.
Meier DT, Rachid L, Wiedemann SJ, Traub S, Trimigliozzi K, Stawiski M, Sauteur L, Winter DV, Le Foll C, Brégère C, Guzman R, Odermatt A, Böni-Schnetzler M, Donath MY. Meier DT, et al. Among authors: le foll c. Nat Commun. 2022 Aug 13;13(1):4761. doi: 10.1038/s41467-022-32509-4. Nat Commun. 2022. PMID: 35963866 Free PMC article.
Lipid sensing in the brain and regulation of energy balance.
Moullé VS, Picard A, Le Foll C, Levin BE, Magnan C. Moullé VS, et al. Among authors: le foll c. Diabetes Metab. 2014 Feb;40(1):29-33. doi: 10.1016/j.diabet.2013.10.001. Epub 2013 Nov 7. Diabetes Metab. 2014. PMID: 24210646 Review.
Physiological and pathophysiological implications of lipid sensing in the brain.
Picard A, Moullé VS, Le Foll C, Cansell C, Véret J, Coant N, Le Stunff H, Migrenne S, Luquet S, Cruciani-Guglielmacci C, Levin BE, Magnan C. Picard A, et al. Among authors: le foll c. Diabetes Obes Metab. 2014 Sep;16 Suppl 1:49-55. doi: 10.1111/dom.12335. Diabetes Obes Metab. 2014. PMID: 25200296 Review.
Metabolic sensing and the brain: who, what, where, and how?
Levin BE, Magnan C, Dunn-Meynell A, Le Foll C. Levin BE, et al. Among authors: le foll c. Endocrinology. 2011 Jul;152(7):2552-7. doi: 10.1210/en.2011-0194. Epub 2011 Apr 26. Endocrinology. 2011. PMID: 21521751 Free PMC article. Review.
55 results